I'm The King of Business & Technology in the Modern World-Chapter 119: Acting on the Plan

The morning after his conversation with Angel, Matthew Borja wasted no time. He arrived at Sentinel Systems HQ before sunrise, coffee in hand, and a mind already racing with the next steps.

The next phase wasn't about vision anymore—it was about execution.

As soon as he stepped into his office, he sent Angel a quick message.

Matthew: "Conference room. 30 minutes. Get everyone relevant."

Angel's response came almost immediately.

Angel: "Already ahead of you. We'll be ready."

Read 𝓁at𝙚st chapters at ƒrēenovelkiss.com Only.

Matthew smirked. That's why she was his right hand.

Thirty minutes later, the main conference room was filled with Sentinel Systems' key department heads. Engineers, legal experts, financial strategists, and logistics specialists—everyone who needed to be involved in launching Sentinel BioTech was in the room.

Angel stood near the screen at the front of the room, tapping her tablet as she organized the presentation.

Matthew took his seat at the head of the table. "Alright, let's not waste time. We've made our decision—Sentinel BioTech is happening. Now we need to make it operational. Angel, walk us through where we are."

Angel nodded and tapped the screen. A slide appeared, outlining the major action points.

"We've begun setting up Sentinel BioTech as a separate LLC under the Sentinel umbrella," Angel began. "Our legal team is handling regulatory compliance, but this isn't like launching a new software division. Bioengineering falls into multiple regulatory categories. We'll need approval from health and safety commissions, biotech oversight boards, and eventually, defense agencies once we step into military applications."

Matthew nodded. "Which means we need a legal team that understands the gray areas. Someone who can navigate these regulations before they even become obstacles."

"I've already reached out to firms specializing in biotech law," Angel said. "But we also need someone inside the system—someone who knows how these agencies operate."

Matthew smirked. "I'll handle that. There's always someone willing to help, for the right price."

Angel moved to the next slide.

"This is the biggest challenge," Angel continued. "We need engineers, AI specialists, materials scientists, and neural interface experts. These people don't just fall out of the sky."

Matthew tapped his fingers on the table. "We recruit aggressively. Internationally. The Philippines won't have the talent pool we need for this, so we poach from the best labs in Japan, Germany, and the U.S."

One of the HR directors hesitated. "That's easier said than done. These engineers are working on classified projects. They're under strict contracts."

"Contracts can be bought out," Matthew said simply. "If the price is right, people will move. And if money isn't enough, freedom is. Most of these engineers work under restrictive conditions. We offer them the chance to lead their own research, not just be another cog in a government-funded project."

Angel nodded. "We're targeting key universities and research labs. I've already identified three startups working on advanced prosthetics and neural interfaces. We can acquire them outright and absorb their talent."

Matthew smirked. "Now we're thinking like a tech empire."

Angel clicked to the next slide. "This is where things get interesting."

The screen displayed a $2 billion funding goal, broken down into three phases:

Private equity and silent investors

Strategic partnerships with industrial giants

Government contracts (eventually)

"We have a few silent backers already interested," Angel continued. "Mainly venture capitalists and industrial players who see the potential. The challenge is keeping this low-profile until we're ready for public exposure."

Matthew leaned back. "Defense contractors?"

Angel hesitated. "Some, but we have to be careful. The moment we take money from major weapons manufacturers, they'll expect control. We need to remain independent."

Matthew nodded. "We'll take private funding first. Keep governments and defense groups at arm's length until we have a finished product. Once we control the tech, they'll come to us on our terms."

The finance director cleared his throat. "R&D alone is going to burn through capital fast. We'll need significant ROI projections for investors."

"We'll handle that by making civilian exoskeletons the first market," Matthew said. "Construction, mining, medical—those industries will pay for enhanced worker efficiency. That revenue funds the military-grade versions."

Angel moved to the next challenge. "Once we have designs, we need a facility to build prototypes. We have a few options:

Partner with an existing manufacturing lab.

Set up our own research & fabrication center."

Matthew tapped the table. "I don't want to be reliant on third-party manufacturers. We build our own facility."

The logistics director hesitated. "That's insanely expensive. We'd need specialized machinery, clean rooms, industrial-scale 3D printers…"

"And we'll get them," Matthew said. "We're not cutting corners on technology this revolutionary. Find a location. We'll buy land, build from the ground up, and make sure every component stays in-house."

Angel made a note. "I'll have a shortlist of potential sites by the end of the week."

After two hours of intense planning, Matthew stood. "Alright, we have a blueprint. Now we move."

Angel closed her tablet. "We're committing serious resources to this, Matthew. This isn't just another software expansion."

"I know," Matthew said. "But this isn't about software. This is about changing the future of human capability."

Angel exhaled. "Then let's get to work."

Over the next two weeks, Sentinel BioTech began taking shape:

Legal teams finalized the subsidiary's registration.

Acquisition negotiations started with three biotech startups specializing in neural integration.

A recruitment team was dispatched to Tokyo and Berlin, targeting top-tier engineers.

A list of potential R&D facility locations was compiled.

Private investors began discreetly committing funds.

One evening, as Matthew reviewed the progress reports in his office, Angel walked in.

"We got confirmation," she said. "The first five engineers we targeted accepted our offers. They're flying in next week."

Matthew smiled. "Good. That's just the beginning."

Angel hesitated. "Are you sure about this? We're stepping into uncharted territory. If we succeed, Sentinel BioTech will change everything. But if we fail…"

"We won't fail," Matthew said. "Because I won't allow it."

Angel studied him for a moment before nodding. "Then I'll see you at the next briefing."

As she left, Matthew turned back to his laptop.

Sentinel BioTech wasn't a concept anymore.

It was real. It was moving.

And soon, the world would have no choice but to recognize its existence.